Response Biomedical gets $2.5 mln loan from Silicon Valley Bank
Response Biomedical Corp (TSX: RBM)(OTCBB: RPBIF) has received a US$2.5 million term loan from Silicon Valley Bank. Headquartered in Vancouver, British Columbia, Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP platform for clinical, biodefense and environmental applications. Update: The company plans to use funds from the loan to support working capital needs for growing its markets both in the United States and internationally, and for general corporate purposes.
12 February 2014•4 mins read
